Comparison of clinical characteristics of second and third peaks of COVID-19 pandemic: effects of vaccination and preventive measures

IF 0.2 Q4 RESPIRATORY SYSTEM Minerva Respiratory Medicine Pub Date : 2022-12-01 DOI:10.23736/s2784-8477.22.02002-2
Özer Özdemir, Atakan Arslan, H. M. Bülbül, P. Özdemir
{"title":"Comparison of clinical characteristics of second and third peaks of COVID-19 pandemic: effects of vaccination and preventive measures","authors":"Özer Özdemir, Atakan Arslan, H. M. Bülbül, P. Özdemir","doi":"10.23736/s2784-8477.22.02002-2","DOIUrl":null,"url":null,"abstract":"BACKGROUND: Understanding the differences in consequent peaks of covid-19 may guide us for better predicting future disease characteristics. in this study, we aimed to compare clinical and radiological characteristics as well as outcomes of hospitalized patients with the diagnosis of covid-19 in second and third peaks of disease. METHOD(S): We retrospectively included 303 hospitalized patients with covid-19. the study population was examined in two groups: patients hospitalized between october 2020 and January 2021 during second peak and patients hospitalized between March and June 2021 during third peak. RESULT(S): there were 171 patients in group 1 and 132 patients in group 2. the patients in group 2 were younger (64+/-13.27 vs. 56.02+/-15.39, respectively;P<0.001) and female proportion was higher (64.9% and 48.5% males;P=0.005). Smoking history and presence of comorbidities were less in group 2 (41.5% vs. 25.7%, P=0.008;and 78.5% vs. 59.1%, P<0.001) and symptom duration was shorter (median 7 days vs. 6 days, P=0.039). CT severity scores, LDH, CRP, D-dimer, Ferritin, and creatinine levels were lower in group 2 (P=0.003, P=0.008, P<0.001, P<0.001, P<0.001, respectively), and mortality ratio was lower (N.=39 [28%] vs. N.=15 [11.4%], P=0.01). Duration of hospital stay and need for intensive unit care were similar across groups (median 8 days vs. 7 days, P=0.673 and N.=39 [22.8%] vs. N.=33 [25.2%], P=0.683). CONCLUSION(S): although duration of hospital stay was lower in third peak, clinical severity scores and prognostic markers were lower compared with second peak. These may reflect the increased proportion of immunized people, and the effect of preventive measures. Copyright © 2022 EDIZIONI MINERVA MEDICA.","PeriodicalId":29817,"journal":{"name":"Minerva Respiratory Medicine","volume":"56 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Minerva Respiratory Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23736/s2784-8477.22.02002-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND: Understanding the differences in consequent peaks of covid-19 may guide us for better predicting future disease characteristics. in this study, we aimed to compare clinical and radiological characteristics as well as outcomes of hospitalized patients with the diagnosis of covid-19 in second and third peaks of disease. METHOD(S): We retrospectively included 303 hospitalized patients with covid-19. the study population was examined in two groups: patients hospitalized between october 2020 and January 2021 during second peak and patients hospitalized between March and June 2021 during third peak. RESULT(S): there were 171 patients in group 1 and 132 patients in group 2. the patients in group 2 were younger (64+/-13.27 vs. 56.02+/-15.39, respectively;P<0.001) and female proportion was higher (64.9% and 48.5% males;P=0.005). Smoking history and presence of comorbidities were less in group 2 (41.5% vs. 25.7%, P=0.008;and 78.5% vs. 59.1%, P<0.001) and symptom duration was shorter (median 7 days vs. 6 days, P=0.039). CT severity scores, LDH, CRP, D-dimer, Ferritin, and creatinine levels were lower in group 2 (P=0.003, P=0.008, P<0.001, P<0.001, P<0.001, respectively), and mortality ratio was lower (N.=39 [28%] vs. N.=15 [11.4%], P=0.01). Duration of hospital stay and need for intensive unit care were similar across groups (median 8 days vs. 7 days, P=0.673 and N.=39 [22.8%] vs. N.=33 [25.2%], P=0.683). CONCLUSION(S): although duration of hospital stay was lower in third peak, clinical severity scores and prognostic markers were lower compared with second peak. These may reflect the increased proportion of immunized people, and the effect of preventive measures. Copyright © 2022 EDIZIONI MINERVA MEDICA.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2019冠状病毒病大流行第二、第三高峰临床特征比较:疫苗接种效果及预防措施
背景:了解covid-19随后高峰的差异可能指导我们更好地预测未来的疾病特征。在本研究中,我们旨在比较在疾病第二和第三高峰诊断为COVID-19的住院患者的临床和影像学特征以及结局。方法:我们回顾性纳入了303例covid-19住院患者。研究人群分为两组:2020年10月至2021年1月期间的第二高峰住院患者和2021年3月至6月期间的第三高峰住院患者。结果:1组171例,2组132例。2组患者年龄较轻(分别为64+/-13.27 vs. 56.02+/-15.39, P<0.001),女性比例较高(男性64.9% vs. 48.5%, P=0.005)。2组吸烟史和合并症发生率较低(41.5%比25.7%,P=0.008; 78.5%比59.1%,P<0.001),症状持续时间较短(中位7天比6天,P=0.039)。2组CT严重程度评分、LDH、CRP、d -二聚体、铁蛋白、肌酐水平均低于对照组(P=0.003、P=0.008、P<0.001、P<0.001、P<0.001),死亡率低于对照组(n =39[28%]比n =15 [11.4%], P=0.01)。住院时间和重症监护需求在两组间相似(中位8天vs. 7天,P=0.673, n =39 [22.8%] vs. n =33 [25.2%], P=0.683)。结论(S):虽然第三高峰住院时间较短,但临床严重程度评分和预后指标较第二高峰低。这可能反映了免疫人群比例的增加,以及预防措施的效果。版权所有©2022 EDIZIONI MINERVA MEDICA。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Minerva Respiratory Medicine
Minerva Respiratory Medicine RESPIRATORY SYSTEM-
CiteScore
1.00
自引率
25.00%
发文量
31
期刊最新文献
Exogenous lipoid pneumonia secondary to repetitive micro-aspiration of paraffin oils laxatives Breathing new life into asthma research: a review of machine learning and multi-omics approaches Enhancing chronic obstructive pulmonary disease management: long-term noninvasive ventilation, ventilation, holistic treatment, monitoring, and artificial intelligence integration Smoking effects on the pulmonary functions and disease activity in rheumatoid arthritis patients: potential value of anticyclic citrullinated peptide assessed in bronchoalveolar lavage High-intensity non-invasive ventilation: a brief review and update
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1